| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: | 1468 | 854 | 336 |
 | Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: | 381 | 328 | 55 |
 | Quantonation Investing in Deep Physics and Quantum Technologies Quantonation is an Early Stage Venture Fund dedicated to Deep Physics startups with a focus on the emerging and disruptive field of Quantum Technologies. After years of R&D, properties such as quantum superposition and entanglement are starting to be harnessed and exploited in a new generation of Quantum Technologies, impacting many sectors by exceeding “classical” devices. Based in Paris, France and Boston, US, Quantonation invests in startups exploiting genuine quantum effects and also in companies leveraging deep physics towards disruptive applications. These include among others cybersecurity, pharmaceutics design, finance and manufacturing. Artificial Intelligence … Sectors: | 222 | 113 | 125 |
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: | 2098 | 1848 | 189 |
 | Financial Times About the Financial Times The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community. Learn more about the FT, including announcements and career opportunities, at aboutus.ft.com. Subscribe at subs.ft.com. One of the world’s leading business news organisations Sectors: | 10595 | 9340 | 476 |
 | Euronext Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 1,930 listed issuers and around €6.8 trillion in market capitalisation as of end March 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total … Sectors: | 981 | 713 | 198 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: | 4497 | 2866 | 644 |
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 12128 | 9203 | 1569 |
 | Sofinnova Partners Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential … | 367 | 189 | 197 |
 | bioMérieux Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. … Sectors: | 414 | 322 | 63 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: | 1865 | 1250 | 257 |
 | Pierre Fabre Laboratories New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: | 736 | 547 | 146 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3440 | 2567 | 830 |
 | Seventure Partners We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences. Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the Planet. With €950m net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe investing since 1997 in innovative businesses with high growth potential in 2 main areas: Life sciences (Biotech, Health & digital Health, Nutrition, Foodtech, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Wellness ...) with a specific interest for … Sectors: | 283 | 170 | 95 |
 | Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: | 976 | 695 | 263 |
 | Medtronic Engineering the extraordinary A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives. Sectors: | 962 | 871 | 27 |
 | Google A problem isn't truly solved until it's solved for all. Googlers build products that help create opportunities for everyone, whether down the street or across the globe. Bring your insight, imagination and a healthy disregard for the impossible. Bring everything that makes you unique. Together, we can build for everyone. Check out our career opportunities at goo.gle/3DLEokh search, ads, mobile, android, online video, apps, machine learning, virtual reality, cloud, hardware, artificial intelligence, youtube, and software Sectors: | 25303 | 19742 | 1090 |
 | Gimv Building Leading Companies for the benefit of our economy and society. Gimv is a European investment company with more than 40 years' experience in private equity. Listed on Euronext Brussels, Gimv currently has EUR 1.5 billion of assets under management. The portfolio contains around 60 portfolio companies, with a combined turnover of EUR 3.7 billion and more than 20,000 employees. As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s five investment platforms are: Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable … | 110 | 42 | 62 |
 | HTGF | High-Tech Gründerfonds Seed Investor. We invest in People. Venture Capital for High-Tech Founders. Made in Germany. HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more … | 882 | 454 | 506 |
 | Amazon Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. We are driven by the excitement of building technologies, inventing products, and providing services that change lives. We embrace new ways of doing things, make decisions quickly, and are not afraid to fail. We have the scope and capabilities of a large company, and the spirit and heart of a small one. Together, Amazonians research and develop new technologies from Amazon Web Services to Alexa on behalf of our customers: shoppers, sellers, content creators, and developers around the … Sectors: | 20505 | 16115 | 806 |
 | Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: | 4708 | 2876 | 636 |
 | Trinity College Dublin Ireland's leading university Trinity College Dublin is recognised internationally as Ireland's premier university and is ranked joint 81st position in the world (QS World University Rankings (2024). In the Times Higher Education World University Rankings, Trinity is ranked 164th in the world. Education, Research, and Innovation Sectors: | 1412 | 827 | 127 |
 | Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: | 1648 | 1066 | 127 |
 | Teva Pharmaceuticals Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please … Sectors: | 1858 | 1014 | 248 |
 | Fresenius Medical Care Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We aim to create a future worth living for chronically and critically ill patients – worldwide and every day. Thanks to our decades of experience in dialysis, our innovative research and our value-based care approach, we can help them to enjoy the very best quality of life. Our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various dialysis treatment options for both in-center and home dialysis that are individually tailored to our patients’ needs. dialysis, hemodialysis, … Tags: DAX30 Sectors: | 518 | 305 | 81 |
 | Oxford Science Enterprises We found, fund and build transformational businesses via our unique partnership with the University of Oxford Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses across specialist areas of life sciences, health tech, AI, new compute, climate tech and agtech. Via our unique partnership with the University of Oxford, the world's #1 research university, we turn the world's most advanced science and technology into companies tackling the world's toughest challenges. In nine years, we have invested £0.7 billion in over 120 ambitious companies built on Oxford science. A key … Sectors: | 269 | 99 | 117 |
 | Noshaq [Automatic translation follows] We offer you financing solutions for the creation and growth of your business. The Noshaq group contributes to the development and economic redeployment of the province of Liège by ensuring long-term financing of business projects. Our holding company has secured a specific place in the Liège financial landscape for over 20 years, with an intervention technique based mainly on taking equity stakes. Noshaq, a leading investment and fund management company, currently supports 460+ SMEs and projects of regional interest. | 235 | 75 | 186 |
 | UCB Inspired by patients. Driven by science. UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and … | 315 | 219 | 95 |
 | Beiersdorf We are skin care. Accompanying people's lives, caring for healthy beautiful skin, nurturing people from the outside in. Beiersdorf has been a pioneer in innovative, high-quality skin care products and groundbreaking skin research for over 140 years. Our internationally beloved brands, including NIVEA – the world’s no. 1 skin care brand –, Eucerin, La Prairie, and Hansaplast, are cherished by millions around the world. Our diverse and trusted portfolio of brands also includes Aquaphor, Coppertone, Chantecaille, Labello, 8x4 and Hidrofugal. With a team of over 20,000 dedicated employees worldwide, Beiersdorf is united by shared core values, a vibrant corporate culture … | 522 | 398 | 46 |
 | BASF We create chemistry for a sustainable future At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Credits: https://www.basf.com/en/tools/legal/credits.html Data … | 4023 | 2518 | 465 |
 | IP Group plc Visionary ventures IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP … | 246 | 83 | 163 |
 | Vinnova Sveriges innovationsmyndighet - vi öppnar upp för innovation som gör skillnad Vinnova is Sweden’s innovation agency. Our mission is to promote sustainable growth by improving the conditions for innovation, as well as funding needs-driven research. Vinnova’s vision is for Sweden to be a world-leading country in research and innovation, an attractive place in which to invest and conduct business. We promote collaborations between companies, universities, research institutes and the public sector. We do this by stimulating a greater use of research, by making long-term investment in strong research and innovation milieus and by developing catalytic meeting places. Vinnova’s activities also … | 459 | 331 | 148 |
 | Chrysalix Venture Capital We build great companies focused on industrial innovation. Chrysalix is a global venture capital fund with a long history commercializing step-change innovation for resource intensive industries. We invest in intelligent systems, energy technology and resource productivity solutions to deliver outsized financial returns and environmental sustainability. By teaming up with leading industrial companies and outstanding entrepreneurs, Chrysalix connects market driven problems to breakthrough solutions. Venture Capital, Clean energy, Robotics, Oil & Gas, Mining, Electric Power, Utilities, Energy, Automation & Manufacturing, Financing, Innovation, Solar, Transportation, Smart Cities, Startups, and Industry 4.0 | 101 | 46 | 57 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1540 | 1406 | 58 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: | 796 | 612 | 69 |
 | Syneos Health Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment. … Sectors: | 137 | 121 | 20 |
 | Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: | 597 | 331 | 75 |
 | Regeneron At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An … Sectors: | 356 | 272 | 21 |
 | Novo Nordisk Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: | 1333 | 1086 | 144 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: | 1746 | 1554 | 121 |
 | Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: | 695 | 549 | 81 |
 | Illumina For Startups Illumina for Startups inspires the creation, funding, and growth of genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include • Startups Grants for founders to work with Illumina sites globally to run proof-of-concept sequencing experiments and • Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, founded in 2021. https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company … Sectors: | 917 | 456 | 155 |
 | Commerzbank AG Commerzbank. The bank at your side Commerzbank is the leading bank for the German Mittelstand and a strong partner for around 25,500corporate client groups and almost 11million private and small-business customers in Germany. The Bank’s two Business Segments –Private and Small-Business Customers and Corporate Clients –offer a comprehensive portfolio of financial services. Commerzbank transacts approximately 30percent of Germany’s foreign trade and is present internationally in more than 40countries in the corporate clients’ business. The Bank focusses on the German Mittelstand, large corporates, and institutional clients. As part of its international business, Commerzbank supports clients with a business relationship to Germany, … | 1295 | 810 | 114 |
 | Duco We’re Duco, and we make managing mission-critical data easy. Our vision is to cut time spent on data-related work in financial services Operations and Finance departments by 90%. Why? Because firms in the industry spend millions of dollars and tens of thousands of hours every year trying to solve data problems. We give you the tools you need to automate all data across your enterprise (regardless of format or source) on one platform, driven by the end-user. It’s a no-code, cloud-native, AI-powered solution that enables you to start trusting your data. This eliminates manual work, cuts cost, reduces risk, turbocharges … Sectors: | 592 | 356 | 60 |
 | AstraZeneca What science can do We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: | 3749 | 2591 | 202 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: | 1608 | 931 | 333 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: | 260 | 184 | 35 |
 | AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: | 920 | 755 | 129 |
 | UK Research and Innovation Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves … Sectors: | 4036 | 2856 | 694 |
 | Lever Offering talent leaders the reach of a marketing leader, forecast of a sales leader, and insight of a finance leader. Lever is a leading Talent Acquisition Suite that makes it easy for talent teams to reach their hiring goals and to connect companies with top talent. Lever is the only platform that provides all talent acquisition leaders with complete ATS and robust CRM capabilities in one product, LeverTRM. The Lever Hire and Lever Nurture features allow leaders to scale and grow their people pipeline, build authentic and long-lasting relationships, and source the right people to hire. Lever Analytics provides customized … Sectors: | 6521 | 4294 | 551 |
Biotechnology